Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 125380, 10 pages
http://dx.doi.org/10.1155/2015/125380
Research Article

LUBAC Formation Is Impaired in the Livers of Mice with MCD-Dependent Nonalcoholic Steatohepatitis

1Division of Molecular Medical Science, Department of Medical Chemistry, Graduate School of Biomedical Sciences, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, Hiroshima Prefecture 734-8551, Japan
2Division of Cervico-Gnathostomatology, Department of Dental Science for Health Promotion, Graduate School of Biomedical Sciences, Hiroshima University, Hiroshima, Hiroshima Prefecture 734-8551, Japan
3Department of Internal Medicine, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan
4Division of Diabetes and Metabolism, The Institute for Adult Diseases, Asahi Life Foundation, 1-6-1 Marunouchi, Chiyoda-ku, Tokyo 100-0005, Japan
5Department of Applied Biological Chemistry, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0033, Japan
6Laboratory of Molecular Cell Biology Institute for Molecular and Cellular Regulation, Gunma University, Maebashi, Gunma 371-8512, Japan
7Department of Molecular and Cellular Physiology, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606-8501, Japan

Received 27 January 2015; Revised 18 May 2015; Accepted 21 May 2015

Academic Editor: Dennis D. Taub

Copyright © 2015 Yasuka Matsunaga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. Sun and M. Karin, “Obesity, inflammation, and liver cancer,” Journal of Hepatology, vol. 56, no. 3, pp. 704–713, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. L. Hebbard and J. George, “Animal models of nonalcoholic fatty liver disease,” Nature Reviews Gastroenterology and Hepatology, vol. 8, no. 1, pp. 34–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. H. Tilg and A. R. Moschen, “Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis,” Hepatology, vol. 52, no. 5, pp. 1836–1846, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A.-C. Tosello-Trampont, S. G. Landes, V. Nguyen, T. I. Novobrantseva, and Y. S. Hahn, “Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-α production,” The Journal of Biological Chemistry, vol. 287, no. 48, pp. 40161–40172, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Miura, L. Yang, N. van Rooijen, D. A. Brenner, H. Ohnishi, and E. Seki, “Toll-like receptor 2 and palmitic acid cooperatively contribute to the development of nonalcoholic steatohepatitis through inflammasome activation in mice,” Hepatology, vol. 57, no. 2, pp. 577–589, 2013. View at Publisher · View at Google Scholar · View at Scopus
  6. M. H. Jarrar, A. Baranova, R. Collantes et al., “Adipokines and cytokines in non-alcoholic fatty liver disease,” Alimentary Pharmacology & Therapeutics, vol. 27, no. 5, pp. 412–421, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. H. Schoemaker, J. E. Ros, M. Homan et al., “Cytokine regulation of pro- and anti-apoptotic genes in rat hepatocytes: NF-κB-regulated inhibitor of apoptosis protein 2 (cIAP2) prevents apoptosis,” Journal of Hepatology, vol. 36, no. 6, pp. 742–750, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Wang and B. Lin, “Inhibitor of apoptosis proteins (IAPs) as regulatory factors of hepatic apoptosis,” Cellular Signalling, vol. 25, no. 10, pp. 1970–1980, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. T. L. Haas, C. H. Emmerich, B. Gerlach et al., “Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction,” Molecular Cell, vol. 36, no. 5, pp. 831–844, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Kirisako, K. Kamei, S. Murata et al., “A ubiquitin ligase complex assembles linear polyubiquitin chains,” The EMBO Journal, vol. 25, no. 20, pp. 4877–4887, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Tokunaga, S.-I. Sakata, Y. Saeki et al., “Involvement of linear polyubiquitylation of NEMO in NF-κB activation,” Nature Cell Biology, vol. 11, no. 2, pp. 123–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. T. Kensche, F. Tokunaga, F. Ikeda, E. Goto, K. Iwai, and I. Dikic, “Analysis of nuclear factor-κB (NF-κB) essential modulator (NEMO) binding to linear and lysine-linked ubiquitin chains and its role in the activation of NF-κB,” The Journal of Biological Chemistry, vol. 287, no. 28, pp. 23626–23634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. F. Ikeda, Y. L. Deribe, S. S. Skånland et al., “SHARPIN forms a linear ubiquitin ligase complex regulating NF-κB activity and apoptosis,” Nature, vol. 471, no. 7340, pp. 637–641, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. F. Tokunaga, T. Nakagawa, M. Nakahara et al., “SHARPIN is a component of the NF-κB-activating linear ubiquitin chain assembly complex,” Nature, vol. 471, no. 7340, pp. 633–636, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. B. Gerlach, S. M. Cordier, A. C. Schmukle et al., “Linear ubiquitination prevents inflammation and regulates immune signalling,” Nature, vol. 471, no. 7340, pp. 591–596, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Tokunaga and K. Iwai, “Linear ubiquitination: a novel NF-κB regulatory mechanism for inflammatory and immune responses by the LUBAC ubiquitin ligase complex,” Endocrine Journal, vol. 59, no. 8, pp. 641–652, 2012. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Sieber, N. Lange, G. Kollmorgen et al., “Sharpin contributes to TNFα dependent NFκB activation and anti-apoptotic signalling in hepatocytes,” PLoS ONE, vol. 7, no. 1, Article ID e29993, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Boisson, E. Laplantine, C. Prando et al., “Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency,” Nature Immunology, vol. 13, no. 12, pp. 1178–1186, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Jung, J. M. Kim, B. Park et al., “Newly identified tumor-associated role of human Sharpin,” Molecular and Cellular Biochemistry, vol. 340, no. 1-2, pp. 161–167, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. E. Seymour, M. G. Hasham, G. A. Cox et al., “Spontaneous mutations in the mouse Sharpin gene result in multiorgan inflammation, immune system dysregulation and dermatitis,” Genes and Immunity, vol. 8, no. 5, pp. 416–421, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Luedde, U. Assmus, T. Wüstefeld et al., “Deletion of IKK2 in hepatocytes does not sensitize these cells to TNF-induced apoptosis but protects from ischemia/reperfusion injury,” Journal of Clinical Investigation, vol. 115, no. 4, pp. 849–859, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. N. Beraza, T. Lüdde, U. Assmus, T. Roskams, S. V. Borght, and C. Trautwein, “Hepatocyte-specific IKKγ/NEMO expression determines the degree of liver injury,” Gastroenterology, vol. 132, no. 7, pp. 2504–2517, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Luedde, N. Beraza, V. Kotsikoris et al., “Deletion of NEMO/IKKgamma in liver parenchymal cells causes steatohepatitis and hepatocellular carcinoma,” Cancer Cell, vol. 11, no. 2, pp. 119–132, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Xu, X. Ma, B. Cui, X. Li, G. Ning, and S. Wang, “Selection of reference genes for qRT-PCR in high fat diet-induced hepatic steatosis mice model,” Molecular Biotechnology, vol. 48, no. 3, pp. 255–262, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. S. Hayden and S. Ghosh, “Shared principles in NF-κB signaling,” Cell, vol. 132, no. 3, pp. 344–362, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Ishii, A. Maeda, S. Tani, and M. Akagawa, “Palmitate induces insulin resistance in human HepG2 hepatocytes by enhancing ubiquitination and proteasomal degradation of key insulin signaling molecules,” Archives of Biochemistry and Biophysics, vol. 566, pp. 26–35, 2015. View at Publisher · View at Google Scholar
  27. Y. Deng, X. Ren, L. Yang, Y. Lin, and X. Wu, “A JNK-dependent pathway is required for TNFα-induced apoptosis,” Cell, vol. 115, no. 1, pp. 61–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Gantke, S. Sriskantharajah, M. Sadowski, and S. C. Ley, “IκB kinase regulation of the TPL-2/ERK MAPK pathway,” Immunological Reviews, vol. 246, no. 1, pp. 168–182, 2012. View at Publisher · View at Google Scholar · View at Scopus